Sort
50,496 grants matching “lung cancer”
BCG overexpressing a small molecule STING agonist as a vaccine for TB
$991,112Todd Wallach · Oncosting Llc · R44 · FY2025 · AI
2/3: The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)
$991,093Christina Ciecierski · Northeastern Illinois University · U54 · FY2020 · CA
Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging
$990,912Robert A Salata · Case Western Reserve University · U54 · FY2021 · CA
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
$990,771Michael T Barrett · Binary Genomics, Inc. · R44 · FY2024 · CA
Development of novel therapeutics for cancer cachexia
$990,411Scott Matthew Ebert · Emmyon, Inc. · R44 · FY2023 · CA
Preclinical Development of Therapeutics in Murine Models of Lung Cancer
$990,320Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Probing functioning lung at the cellular resolution in health and disease
$990,000Hadi Tavakoli Nia · Boston University (Charles River Campus) · DP2 · FY2025 · HL
Reducing Cancer Health Disparities in Detroit
$989,994Ann G Schwartz · Wayne State University · P20 · FY2022 · CA
Mass Spectrometry Quantitation
$989,919Leesa Deterding · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES
A Phase II Trial of ACAPHA in Former Smokers with IEN.
$989,903British Columbia Cancer Agency · U01 · FY2004 · CA
Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer
$989,826Eliseu O. De Oliveira · Coare Holdings, Inc. · R44 · FY2021 · CA
Genetic Toxicity Testing Services for the NTP
$989,488Les Recio · Integrated Laboratory Systems, Llc · N01 · FY2018 · ES
CardioWatch: An Omics-Based Prediction Assay for Cardiac Late Effects ofAcute Radiation
$989,322Tomas Kanholm · Nelson Scientific Labs Llc · R44 · FY2024 · AI
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
$989,251Alan S. Wayne · Children'S Hospital Of Los Angeles · U01 · FY2023 · AI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$989,186Chetan Seshadri · University Of Washington · R01 · FY2025 · AI
Phase I Clinical Testing of a First-in-Class Therapy against Metastatic Cancer
$988,765Zdravka O. Medarova · Transcode Therapeutics, Inc. · R44 · FY2025 · CA
Pharmacogenetic Studies
$988,591Neil E. Caporaso · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
ACQUISITION OF THE INVEON SMALL ANIMAL PET/CT SYSTEM
$988,523Richard Andre Laforest · Washington University · S10 · FY2009 · RR
Optimizing Implementation in Cancer Control: OPTICC
$988,432Bryan J. Weiner · University Of Washington · P50 · FY2019 · CA
Risk prediction methods
$988,223Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
PathMAP NSCLC: A functional companion diagnostic test to predict optimal therapy for patients with non-small cell lung cancer.
$988,207Greg Bertenshaw · Biomarker Strategies, Llc · R44 · FY2017 · CA
Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent
$988,000Ke Zhang · Pacdna Llc · R42 · FY2024 · CA
Red Cell Biology
$987,510David M. Bodine · National Human Genome Research Institute · ZIA · FY2019 · HG
Northwestern Cancer Prevention Consortium
$987,500Seema Ahsan Khan · Northwestern University At Chicago · UG1 · FY2019 · CA
DIESEL PARTICLE EXPOSURE AND LUNG CANCER
$987,450Brigham And Women'S Hospital · R01 · FY2002 · CA